Veterinary Medicines

TYLMASIN 250 mg/g premix for medicated feeding stuff

Authorised
  • Tylosin phosphate
Download as PDF

Product identification

Medicine name:
TYLMASIN 250 mg/g premix for medicated feeding stuff
Pharmasin 250 mg/g pré-mistura medicamentosa para alimento medicamentoso para suínos, galinhas e frangos
Active substance:
  • Tylosin phosphate
Target species:
  • Pig
  • Chicken
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Tylosin phosphate
    250.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Pig
      • Meat and offal
        0
        day
    • Chicken
      • Meat and offal
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • bag of 20 kg
  • bag of 5 kg
  • sachet of 1 kg

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 969/01/15DFVPT
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0225/001
Concerned member states:
  • Italy
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/04/2023
Download

Package Leaflet

English (PDF)
Published on: 11/04/2023
Download

Labelling

English (PDF)
Published on: 11/04/2023
Download

eu-PUAR-tylmasin-250-mg-g-premix-for-medicated-feeding-stuff-en.pdf

English (PDF)
Published on: 11/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."